Article
Hydrostatic balloon dilatation of Crohn's strictures.
Department of Gastroenterology, Hôpital Saint-Louis, Paris, France.
Alimentary Pharmacology & Therapeutics (impact factor:
3.77).
09/2003;
18(4):409-13.
pp.409-13
Source: PubMed
-
Citations (0)
- Cited In (4)
-
Article: Endoscopic evaluation of patients with inflammatory bowel disease.
[show abstract] [hide abstract]
ABSTRACT: Endoscopy plays a critical role in the diagnosis and management of inflammatory bowel disease (IBD). This article reviews the utility of endoscopy in the diagnosis of ulcerative colitis (UC) and Crohn's disease (CD), recommendations for cancer surveillance, and the use of newer techniques for the enhanced detection of dysplasia in chronic UC. Finally, the use of endoscopy for the management of certain complications of IBD is also discussed.Inflammatory Bowel Diseases 03/2008; 14(9):1287-97. · 4.86 Impact Factor -
Article: Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trial.
[show abstract] [hide abstract]
ABSTRACT: Endoscopic balloon dilation (EBD) is an attractive conservative therapy for Crohn's disease (CD) with stricture; however, its long-term efficacy has been questioned because many patients require more dilations or postdilation surgery. Most reports are retrospective, and no pediatric data are available. To assess the effectiveness of corticosteroid intralesional injection after EBD in preventing stricture recurrence. Single-center prospective, randomized, double-blind, controlled trial. Tertiary-referral university hospital. Between November 2005 and January 2009, 29 pediatric patients with stricturing CD were enrolled. Enrolled patients were randomized to receive intrastricture injection of corticosteroid (CS) (n = 15) or placebo (n = 14) after EBD. Patients were followed clinically via small intestine contrast US and intestinal magnetic resonance imaging at 1, 3, 6, and 12 months; all underwent colonoscopy 12 months after dilation. Time free of repeat dilation and time free of surgery in the 2 groups. One of the 15 patients receiving CS required redilation, whereas the latter was needed in 5 of the 14 placebo patients; surgery was needed in 4 of the placebo patients, but in none of those receiving CS. The 2 groups statistically differed in the time free of redilation (P = .04) as well as for time free of surgery after EBD (P = .02), which were worse in the placebo group compared with the CS group. There were no significant differences in baseline demographics between the 2 groups. Sample size, participation bias, and short-term follow-up. In pediatric CD with stricture, intralesional CS injection after EBD is an effective strategy for reducing the need both for redilation and surgery.Gastrointestinal endoscopy 10/2010; 72(6):1201-8. · 6.71 Impact Factor -
Article: Practice parameters for the surgical management of Crohn's disease.
Diseases of the Colon & Rectum 12/2007; 50(11):1735-46. · 3.13 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
1 year
38 patients
5 years
53 dilatation sessions
acceptable rate
colocolic
Complications
concomitant medical therapies
Crohn's disease
Crohn's symptomatic strictures
Hydrostatic balloon dilatation
intestinal symptomatic strictures
last news
long-term efficacy
obstructive symptom recurrence
one perforation
patients
per-endoscopic hydrostatic balloon dilatation
retrospective series
Matthieu Allez |